Optimal selection of screening assays for infectious agents in donated blood

IIE Transactions on Healthcare Systems Engineering

Volumn 1, Issue 2, 2011, Pages 67-90

  Bish, Douglas R ^a   Bish, Ebru K ^a   Xie, Shiguang R ^a   Slonim, Anthony D ^b  

^a State University   (United States)

^b CARILION CLINIC   (United States)

Author keywords

blood safety; blood screening; heuristics; knapsack problem; Resource allocation

Indexed keywords

ALGORITHM; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION; MIXED INFECTION; NONHUMAN; OUTCOME ASSESSMENT; PATHOGEN LOAD; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROCESS OPTIMIZATION; RISK; SCREENING; SENSITIVITY AND SPECIFICITY; TRANSFUSION TRANSMITTED INFECTION; WEST NILE FLAVIVIRUS;

EID: 84905243104     PISSN: 19488300     EISSN: 19488319     Source Type: Journal    
DOI: 10.1080/19488300.2011.609520     Document Type: Article

References (87)

1. Adams, W. P. and Sherali, H. D. 1990. Linearization strategies for a class of zero-one mixed integer programming problems. Operations Research, 38: 217-226.
2. Adewole, O. O., Anteyi, E., Ajuwon, Z., Wada, I., Elegba, F., Ahmed, P., Betiku, Y., Okpe, A., Eze, S., Ogbeche, T. and Erhabor, G. E. 2009. Hepatitis B and C Virus co-infection in Nigerian patients with HIV infection. The Journal of Infection in Developing Countries, 3(5): 369-375.
3. Alter, M. J. 2006. Epidemiology of viral Hepatitis and HIV co-infection. Journal of Hepatology, 44: S6-S9.
4. American Red Cross. 2008. Arm to arm, 2nd ed, Author.
5. AuBuchon, J. P., Birkmeyer, J. D. and Busch, M. P. 2003. Cost-effectiveness of expanded Human Immunodeficiency Virus-testing protocols for donated blood. Transfusion, 37(1): 45-51.
6. Beutel, J. 2000. Handbook of medical imaging: medical image processing and analysis, 6th ed., Bellingham, Wash: SPIE Press.
7. Biggerstaff, B. J. and Petersen, L. R. 2002. Estimated risk of West Nile Virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion, 42(8): 1019-1026.
8. Bihl, F., Castelli, D., Marincola, F., Dodd, R. Y. and Brander, C. 2007. Transfusion-transmitted infections. Journal of Translational Medicine, 5: 25-27.
9. BloodBook. 2010. Blood transfusion risks - Regional differences in blood transmitted diseases http://www.bloodbook.com/trans-risk.html, accessed on April 2010.
10. Bonacini, M., Govindarajan, S., Blatt, L. M., Schmid, P., Conrad, A. and Lindsay, K. L. 1999. Patients co-infected with Human Immunodeficiency Virus and Hepatitis C Virus demonstrate higher levels of Hepatic HCV RNA. Journal of Viral Hepatitis, 6(3): 203-208.
11. Bonacini, M., Lin, H. J. and Hollinger, F. B. 2001. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of Hepatitis C Virus. Journal of Acquired Immune Deficiency Syndromes, 26(4): 340-344.
12. Brandeau, M.L. 2005. "Allocating resources to control infectious diseases". In Operations research and health care: A Handbook of methods and applications, 1st ed., 443-464. New York: Springer.
13. Bretthauer, K. M. and Shetty, B. 2002. The nonlinear knapsack problem-Algorithms and applications. European Journal of Operational Research, 138: 459-472.
14. Busch, M., Walderhaug, M., Custer, B., Allain, J. P., Reddy, R. and McDonough, B. 2009. Risk assessment and cost-effectiveness/utility analysis. Biologicals, 37: 78-87.
15. Carmo, R.A., Lima, A.A., Andrade, C.A., Oliveira, J.G., Oliveira, M.S., Santi, L.Q., Bicalho, H.N. and Silva, S.M. 2000. "Epidemiological study of Hepatitis C Virus (HCV)/HIV coinfection in Brazil". In Int Conf AIDS Jul 9-14, 13, ab. no. WeOrA531.
16. Chang, C. and Chang, C. 2000. A linearization method for mixed 0-1 polynomial programs. Computers & Operations Research, 27(10): 1005-1016.
17. Chern, M-S. 1992. On the computational complexity of reliability redundancy allocation in a series system. Operations Research Letters, 11(5): 309-315.
18. Choudhury, N. 2010. Transfusion transmitted infections: How many more. Asian Journal of Transfusion Science, 4: 71-72.
19. Christian, B., Okuma, J. and Hawkins, C. 2010. "Prevalence of Hepatitis B and C co-infection and response to antiretroviral therapy among HIV-infected patients in an urban setting in Tanzania". In 17th Conference on Retroviruses & Opportunistic Infections (CROI 2010) Feb 16-19, 694.
20. Custer, B., Busch, M., Marfin, A. A. and Petersen, L. R. 2005. The cost-effectiveness of screening the U.S. blood supply for the West Nile Virus. Annals of Internal Medicine, 143: 486-492.
21. Dodd, R. Y., Notari, E. P. and Stramer, S. L. 2002. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion, 42: 975-979.
22. Dow, B. C. 2000. 'Noise' in microbiological screening assays. Transfusion Medicine, 10(2): 97-106.
23. Dreyfus, S. E. 1969. An appraisal of some shortest-path algorithms. Operations Research, 17(3): 395-412.
24. Dzik, W. H. 2003. Emily Cooley lecture 2002: Transfusion safety in the hospital. Transfusion, 43(9): 1190-1199.
25. Eble, B. E., Busch, M. P., Guiltinan, A. M., Khayam-Bashi, H. and Murphy, E. L. 1993. Determination of Human T Lymphotropic Virus type by polymerase chain reaction and correlation with risk factors in northern California blood donors. Journal of Infectious Diseases, 167(4): 954-957.
26. FDA. 2010. Complete list of donor screening assays for infectious agents and HIV diagnostic assays, Food and Drug Administration. http://www.fda.gov/BiologicsBloodVaccines/Blood BloodProducts/Approved Product s/LicensedProductsBLAs/Blood DonorScreening/InfectiousDisease/ucm080466.htm, accessed on April 2010.
27. FDA. 2011. Food and Drug Administration. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/default.htm, accessed on January 2011.
28. Field, S. P. and Allain, J. P. 2007. Transfusion in sub-Saharan Africa - Does a Western model fit. Journal of Clinical Pathology, 60: 1073-1075.
29. Forbi, J. C., Gabadi, S., Alabi, R., Iperepolu, H. O., Pam, C. R., Entonu, P. E. and Agwale, S. M. 2007. The role of triple infection with Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria. Memorias do Instituto Oswaldo Cruz, 102(4): 535-537.
30. Garey, M.R. and Johnson, D.S. 1979. Computers and Intractability: A Guide to the Theory of NP-completeness, San Francisco: W.H. Freeman.
31. Glover, F. and Woolsey, E. 1974. Technical note - converting the 0-1 polynomial programming problem to a 0-1 linear program. Operations Research, 22(1): 180-182.
32. Gordona, S. C. and Sherman, K. E. 2009. Treatment of HBV/HCV coinfection: Releasing the enemy within. Gastroenterology, 136(2): 393-396.
33. Greinacher, A., Fendrich, K., Alpen, U. and Hoffmann, W. 2007. Impact of demographic changes on the blood supply: Mecklenburg-West Pomerania as a model region for Europe. Transfusion, 47(3): 395-401.
34. Hay, S. N., Scanga, L. and Brecher, M. E. 2006. Life, death, and the risk of transfusion: A University hospital experience. Transfusion, 46(9): 1491-1493.
35. Hillyer, C.D. 2001. Handbook of Transfusion Medicine, San Diego, CA: Academic Press.
36. Hsieh, Y-C. 2002. A linear approximation for redundant reliability problems with multiple component choices. Computers & Industrial Engineering, 44: 91-103.
37. Jackson, B. R., Busch, M. P., Stramer, S. L. and AuBuchon, J. P. 2003. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion, 43: 721-729.
38. Jafa, K., Patel, P., MacKellar, D. A., Sullivan, P. S., Delaney, K. P., Sides, T. L., Newman, A. P., Paul, S. M., Cadoff, E. M. and Martin, E. G. 2007. Investigation of false positive results with an Oral Fluid Rapid HIV-1/2 antibody test. PLoS One, 2(1): e185
39. Kiire, C. F. 1996. The epidemiology and prophylaxis of Hepatitis B in sub-Saharan Africa: A view from tropical and subtropical Africa. Gut, 38(Suppl. 2): S5-S12.
40. Lackritz, E., Campbell, C. and Ruebush, T. 1992. Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet, 340: 524-528.
41. Lal, R.B., Owen, S.M., Mingle, J., Levine, P.H. and Manns, A. 1994. Presence of Human T Lymphotropic Virus types I and II in Ghana, West Africa. AIDS Res Hum Retroviruses, Dec 10(12): 1747-1750.
42. Lancet Editorial. 2005. Blood supply and demand. The Lancet, 365: 9478-12151.
43. Lander, J. J., Gitnick, G. L., Gelb, L. H. and Aach, R. D. 2009. Anticore antibody screening of transfused blood. Vox Sanguinis, 34(2): 77-80.
44. Lara, A. M., Kandulu, J., Chisuwo, L., Kashoti, A., Mundy, C. and Bates, I. 2007. Labaratory costs of a hospital-based blood transfusion service in Malawi. Journal of Clinical Pathology, 58: 56-60.
45. Lefrere, J. J., Coste, J., Defer, C., Loiseau, P., Portelette, E., Mariotti, M., Lerable, J., Rouger, P. and Pawlotsky, J. M. 1998. Screening blood donations for viral genomes: Multicenter study of real-time simulation using pooled samples on the model of Hepatitis C Virus RNA detection. Transfusion, 38(10): 915-923.
46. Leiby, D.A. 2001. "Parasites and other emergent infectious agents". In Blood Safety in the New Millenium, Edited by: Stramer, S.L. 55-78. Bethesda, MD: American Association of Blood Banks.
47. Li, D. and Sun, X. 2006. Nonlinear Integer Programming, New York: Springer.
48. Lincoln, D., Petoumenos, K. and Dore, G. J. 2003. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Medicine, 4: 241-249.
49. Lindsay, G. F. and Bishop, A. B. 1964. Allocation of screening inspection effort-A dynamic-programming approach. Management Science, 10: 342-352.
50. Madhava, V., Burgess, C. and Drucker, E. 2002. Epidemiology of chronic Hepatitis C Virus infection in sub-Saharan Africa. The Lancet Infectious Disease, 2: 293-302.
51. Marshall, D. A., Kleinman, S. H., Wong, J. B., AuBuchon, J. P., Grima, D. T., Kulin, N. A. and Weinstein, M. C. 2004. Cost-effectiveness of Nucleic Acid Test screening of volunteer blood donations for Hepatitis B, Hepatitis C and Human Immunodeficiency Virus in the United States. Vox Sanguinis, 86: 28-40.
52. Martello, S. and Toth, P. 1990. Knapsack problems: Algorithms and computer implementation, New York: John Wiley and Sons.
53. McFarland, W., Mvere, D., Shandera, W. and Reingold, A. 2003. Epidemiology and prevention of transfusion-associated Human Immunodeficiency Virus transmission in Sub-Saharan Africa. Vox Sanguinis, 72(2): 85-92.
54. Moore, M. C., Howell, D. R. and Barbara, J. A. 2007. Donors whose blood reacts falsely positive in transfusion microbiology screening assays need not be lost to transfusion. Transfusion Medicine, 17: 55-59.
55. Mostashari, F., Bunning, M. L., Kitsutani, P. T., Singer, D. A., Nash, D., Cooper, M. J., Katz, N., Liljebjelke, K. A., Biggerstaff, B. J., Fine, A. D., Layton, M. C., Mullin, S. M., Johnson, A. J., Martin, D. A., Hayes, E. B. and Campbell, G. L. 2001. Epidemic West Nile Encephalitis, New York, 1999: Results of a household-based seroepidemiological survey. Lancet, 358: 261-264.
56. ORD. 2011. Office of Rare Diseases (ORD) of the National Institutes of Health (NIH), West Nile fever: Rare Disease. http://www.wrongdiagnosis.com/w/west_nile_fever/prevalence.htm?ktrack=kcplink, accessed on January 2011.
57. Orfinger, B. 2000. Red Cross calls national blood shortage a disaster http://www.redcross.org/news/inthnews/00/7-12a-00.html, accessed on July 2010.
58. Otegbayo, J. A., Taiwo, B. O., Akingbola, T. S., Odaibo, G. N., Adedapo, K. S., Penugonda, S., Adewole, I. F., Olaleye, D. O., Murphy, R. and Kanki, P. 2008. Prevalence of Hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Annals of Hepatology, 7(2): 152-156.
59. Owusu-Ofori, S., Asenso-Mensah, K., Boateng, P., Sarkodie, F. and Allain, J. P. 2010. Fostering repeat donations in Ghana. Biologicals, 38: 47-52.
60. Ozekici, S. and Pliska, S. 1991. Optimal scheduling of inspections: A delayed Markov model with false positive and negatives. Operations Research, 39(2): 261-273.
61. Pepe, M.S. 2004. The Statistical Evaluation of Medical Tests for Classification and Prediction, Oxford, UK: Oxford University Press.
62. Petersen, L.R. 2009. West Nile Encephalitis Virus Infection, New York, NY: Springer.
63. Proietti, F. A., Carneiro-Proietti, A.B. F., Catalan-Soares, B. C. and Murphy, E. L. 2005. Global epidemiology of HTLV I infection and associated diseases. Oncogene, 24: 6058-6068.
64. Raz, T. 1986. A survey of models for allocating inspection effort in multistage production systems. Journal of Quality Technology, 18(4): 239-247.
65. Raz, T. and Kaspi, M. 1991. Location and sequencing of imperfect inspection operations in serial multi-stage production systems. International Journal of Production Research, 29(8): 1645-1659.
66. Richard, L., Pellegrin, J. L., Barbeau, P., Brossard, G., Leng, B. and Fleury, H.J.A. 1993. HIV-1 and HCV co-infected patients: Detection of active viral expression using a nested polymerase chain reaction. Molecular and Cellular Probes, 7(5): 405-410.
67. Sayre, K. R., Dodd, R. Y., Tegtmeier, G., Layug, L., Alexander, S. S. and Busch, M. P. 1996. False-positive Human Immunodeficiency Virus type 1 Western blot tests in non-infected blood donors. Transfusion, 36(1): 45-52.
68. Schmunis, G. A., Zicker, F., Pinheiro, F. and Brandling-Bennett, D. 1998. Risk for transfusion-transmitted infectious diseases in Central and South America. Emerging Infectious Diseases, 4(1): 5-11.
69. Schwartz, J. S., Kinosian, B. P., Pierskalla, W. P. and Lee, H. 1990. Strategies for screening blood for Human Immunodeficiency Virus antibody. Journal of the American Medical Association (JAMA), 264(13): 1704-1710.
70. Sendi, P., Al, M. J., Gafni, A. and Birch, S. 2003. Optimizing a portfolio of healthcare programs in the presence of uncertainty and constrained resources. Social Science & Medicine, 57(9): 2207-2215.
71. Sherali, H. D. and Tuncbilek, C. H. 1992. A global optimization algorithm for polynomial programming problems using a Reformulation-Linearization Technique. Journal of Global Optimization, 2: 101-112.
72. Soriano, V., Barreiro, P. and Nunez, M. 2006. Management of chronic Hepatitis B and C in HIV-coinfected patients. Journal of Antimicrobial Chemotherapy, 57(5): 815-818.
73. Sungkanuparph, S., Vibhagool, A., Manosuthi, W., Kiertiburanakul, S., Atamasirikul, K., Aumkhyan, A. and Thakkinstian, A. 2004. Prevalence of Hepatitis B Virus and Hepatitis C Virus co-infection with Human Immunodeficiency Virus in Thai patients: A tertiary-care-based study. Journal of the Medical Association of Thailand, 87(11): 1349-1354.
74. UNAIDS. 2008. Report on the global AIDS epidemic, technical report http://www.unaids.org/en/knowledgecentre/hivdata/globalreport/2008/2008_global_report.asp, accessed January 2011.
75. Van Hulst, M., Hubben, G.A. A., Kwamena, W.C. S., Promwong, C., Permpikul, P., Fongsatikul, L., Glynn, D. M., Sibinga, C.T. S. and Postma, M. J. 2009. Web interface supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: A global model applied to Ghana, Thailand, and the Netherlands. Transfusion, 49: 2729-2742.
76. Van Hulst, M., Sibinga, C.T. S. and Postma, M. J. 2010. Health economics of blood transfusion safety-Focus on sub-Saharan Africa. Biologicals, 38: 53-58.
77. Vrielinka, H. and Reesink, H. W. 2004. HTLV I/II prevalence in different geographic locations. Transfusion Medicine Reviews, 18(1): 46-57.
78. Walkley, A. 2009. HIV transmission via transfusions in Africa remains high http://www.mediaglobal.org/article/2010-01-04/hiv-transmission-via-transfusions-in-africa-remains-high, accessed on April 2010.
79. Walter, S. D. and Irwig, L. M. 1988. Estimation of test error rates, disease prevalence, and relative risk from misclassified data: A review. Journal of Clinical Epidemiology, 41: 923-937.
80. Whitaker, B.I., Green, J., King, M.R., Leibeg, L.L., Mathew, S.M., Schlumpf, K.S. and Schreiber, G.B. 2007. The United States Department of Health and Human Services 2007 National Blood Collection and Utilization Survey Report. accessed January 2011.
81. WHO. 2004. Developing countries face safe blood shortage. Bulletin of World Health Organization [online], 82(7): 558-558.
82. WHO. 2010a. 10 facts on blood transfusion, World Health Organization. http://www.who.int/features/factfiles/blood_transfusion/en/index.html, accessed on April 2010.
83. WHO. 2010b. WHO global database on blood safety and blood safety indicators, World Health Organization. http://www.who.int/bloodsafety/global_database/en/, accessed on April 2010.
84. WHO. 2011. Screening donated blood for transfusion-transmissible infections-Recommendations, World Health Organization. http://www.who.int/bloodsafety/ScreeningDonatedBloodforTransfusion.pdf, accessed on January 2011.
85. Xie, R.S., Bish, D.R., Bish, E.K., Slonim, A.D. and Stramer, S.L. 2011. Safety and waste considerations in donated blood screening Submitted and under review.
86. You, P-S and Chen, T-C. 2005. An efficient heuristic for series-parallel redundant reliability problems. Computers & Operations Research, 32: 2117-2127.
87. Zacharias, N. M., Athanassaki, I. D., Sangi-Haghpeykar, H. and Gardner, M. O. 2004. High false-positive rate of Human Immunodeficiency Virus rapid serum screening in a predominantly Hispanic prenatal population. Journal of Perinatology, 24(12): 743-747.